Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
- First Posted Date
- 2014-05-21
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 35
- Registration Number
- NCT02143726
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Nebraska Methodist Hospital, Omaha, Nebraska, United States
🇺🇸Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2014-04-17
- Last Posted Date
- 2020-05-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 401
- Registration Number
- NCT02116530
- Locations
- 🇺🇸
Southwest Oncology PC, Durango, Colorado, United States
🇺🇸Saint Luke's Mountain States Tumor Institute - Nampa, Nampa, Idaho, United States
🇺🇸Illinois CancerCare Galesburg, Galesburg, Illinois, United States
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2013-12-09
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 118
- Registration Number
- NCT02004275
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸Riverside Methodist Hospital, Columbus, Ohio, United States
🇺🇸NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
- Conditions
- Interventions
- First Posted Date
- 2013-10-01
- Last Posted Date
- 2023-08-31
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1473
- Registration Number
- NCT01953588
- Locations
- 🇺🇸
Mercy Medical Center, Springfield, Massachusetts, United States
🇺🇸Southwest Oncology PC, Durango, Colorado, United States
🇺🇸Epic Care-Dublin, Dublin, California, United States
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2013-09-24
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1311
- Registration Number
- NCT01949337
- Locations
- 🇺🇸
Greenville Health System Cancer Institute-Easley, Easley, South Carolina, United States
🇺🇸University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
🇺🇸UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2013-07-23
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 161
- Registration Number
- NCT01905046
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States
🇺🇸Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, United States
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2013-07-17
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 2012
- Registration Number
- NCT01901094
- Locations
- 🇺🇸
Mount Carmel East Hospital, Columbus, Ohio, United States
🇺🇸Grant Medical Center, Columbus, Ohio, United States
🇺🇸The Mark H Zangmeister Center, Columbus, Ohio, United States
Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2013-04-24
- Last Posted Date
- 2018-01-30
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 106
- Registration Number
- NCT01838434
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients With Pancreatic Cancer
- Conditions
- Interventions
- First Posted Date
- 2013-04-01
- Last Posted Date
- 2018-09-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 23
- Registration Number
- NCT01821612
- Locations
- 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
🇺🇸Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
🇺🇸University of Cincinnati, Cincinnati, Ohio, United States
Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
- Conditions
- Interventions
- First Posted Date
- 2013-03-20
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 90
- Registration Number
- NCT01814813
- Locations
- 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸Piedmont Hospital, Atlanta, Georgia, United States
🇺🇸Emory University/Winship Cancer Institute, Atlanta, Georgia, United States